A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis

NCT03521232 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Covid-19

Conditions

Ulcerative Colitis
Ulcerative Proctitis
Ulcerative Proctosigmoiditis

Interventions

DRUG: Niclosamide

Sponsor

Entero Therapeutics